Skip to content

Clinical study of postoperative adjuvant therapy in locally advanced oral squamous cell carcinoma

Clinical study of postoperative adjuvant therapy in locally advanced oral squamous cell carcinoma - Clinical study of postoperative adjuvant therapy in oral cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000033453
Enrollment
50
Registered
2018-07-20
Start date
2018-08-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oral squamous cell carcinoma

Interventions

None listed

Sponsors

Nagasaki University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patient whose primary tumor is histologically confirmed as oral squamous cell carcinoma. 2. Patient who is the primary case. 3. Patients who underwent radiotherapy or chemoradiotherapy as postoperative adjuvant therapy

Exclusion criteria

Exclusion criteria: 1. Patient who is a local recurrence case 2. Patient other than primary case. 3. In addition, patients whose research managers judged inappropriate as subjects.

Design outcomes

Primary

MeasureTime frame
5 year Overall survival

Countries

Japan

Contacts

Public ContactSouichi Yanamoto

Nagasaki University Hospital, Dentistry for Medically Compromised Patient

syana@nagasaki-u.ac.jp095-819-7698

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026